When Conventional Oxygen Therapy Fails—The Effectiveness of High-Flow Nasal Oxygen Therapy in Patients with Respiratory Failure in the Course of COVID-19

High-flow nasal oxygen (HFNO) is recommended as a first-line treatment in patients with acute hypoxemic respiratory failure due to COVID-19. We assessed the effectiveness of HFNO and predictors of failure and death. The medical records of 200 consecutive adult patients treated with HFNO were analyse...

Descripción completa

Detalles Bibliográficos
Autores principales: Rorat, Marta, Szymański, Wojciech, Jurek, Tomasz, Karczewski, Maciej, Zelig, Jakub, Simon, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541059/
https://www.ncbi.nlm.nih.gov/pubmed/34682874
http://dx.doi.org/10.3390/jcm10204751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541059/
https://www.ncbi.nlm.nih.gov/pubmed/34682874
http://dx.doi.org/10.3390/jcm10204751

Ejemplares similares